Virus Filtration Market Report 2026

Virus Filtration Market Overview

• Virus Filtration market size has reached to $5.94 billion in 2025 • Expected to grow to $10.81 billion in 2030 at a compound annual growth rate (CAGR) of 12.8% • Growth Driver: Rising Incidence Of Chronic Diseases Fuels Growth In The Virus Filtration Market • Market Trend: Advancement Of High-Flux Filtration Technologies Driving Enhanced Bioprocess Efficiency • North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under Virus Filtration Market?

Virus filtration is a method by which the physical removal of potential viruses is achieved from the manufacturing process streams. Virus filters provide a key line of defense against the introduction of adventitious viruses into this important class of medicines. Virus filters are distinct from other filter types in that filter manufacturers have evaluated and optimized the robustness and efficiency of their virus removal performance and have developed integrity tests correlated to virus removal. The main types of virus filtration are kits and reagents, services, filtration systems, and others. The kit is a sterile tubing system that enables the transfer of radioactive proteins between a labeling (reaction) vessel and a purification column using peristaltic pumps. A reagent is a substance or compound that can facilitate a reaction, and they are widely used tests. Reagents are used in test kits for virus filtration. The virus filtration is used by pharmaceutical and biotechnology companies, contract research organizations, academic research institutes, and medical device companies in applications such as medical devices, water purification, air purification, biologicals, vaccines and therapeutics, blood and blood products, cellular and gene therapy products, and others.

What Is The Virus Filtration Market Growth Forecast?

The virus filtration market size is expected to see rapid growth in the next few years. It will grow to $10.81 billion in 2030 at a compound annual growth rate (CAGR) of 12.8%. The growth in the forecast period can be attributed to growth in cell and gene therapies, expansion of biomanufacturing capacity, stricter regulatory standards, rising biologics pipeline, demand for contamination free production. Major trends in the forecast period include rising demand for biopharmaceutical safety, expansion of gene and cell therapy manufacturing, growing adoption of single use filtration systems, increased focus on process validation, rising use in vaccine production.

Tariff Impact On Virus Filtration Market

Tariffs have affected the virus filtration market by increasing the cost of imported membranes, filtration housings, testing reagents, and specialized consumables. Filtration systems and kits are most impacted, particularly in North America and Europe. Higher costs have influenced procurement strategies for biopharma companies. At the same time, tariffs have encouraged regional manufacturing of filtration components and strengthened local supply chains.

Global Virus Filtration Market Segmentation

1) By Product Type: Virus Filtration Devices, Virus Filtration Consumables, Virus Filtration Systems, Virus Filtration Services 2) By Filtration Technology: Size-Exclusion Virus Filtration, Membrane-Based Virus Filtration, Hollow Fiber Virus Filtration, Flat-Sheet Virus Filtration 3) By Application: Monoclonal Antibodies, Recombinant Proteins, Vaccines, Blood and Plasma-Derived Products, Cell and Gene Therapy Products, Other Biologic Therapeutics 4) By End User: Pharmaceutical Companies, Biotechnology Companies, Contract Development and Manufacturing Organizations (CDMOs), Contract Research Organizations Subsegments: 1) By Virus Filtration Devices: Single-Use Virus Filters, Reusable Virus Filters 2) By Virus Filtration Consumables: Virus-Rated Filter Cartridges, Virus-Rated Filter Capsules, Integrity Testing Accessories 3) By Virus Filtration Systems: Stand-Alone Virus Filtration Skids, Integrated Bioprocessing Filtration Systems 4) By Virus Filtration Services: Virus Clearance Validation Services, Filter Integrity Testing Services, Virus Removal Study Services

What Are The Drivers Of The Virus Filtration Market?

The increasing number of chronic diseases is a major driver propelling the growth of the virus filtration market. Chronic diseases refer to conditions that last 1 year or more and need ongoing medical attention or limit activities of daily living. Virus filtration aids in preventing infectious and chronic diseases by removing viruses effectively, supporting the growth of the market. For instance, in June 2023, the Institute for Health Metrics and Evaluation, a US-based public health research institute, reported that over half a billion people globally were living with diabetes. This number is expected to more than double, reaching 1.3 billion people by 2050. Therefore, the rising frequency of cardiovascular illnesses will continue to drive the growth of the virus filtration industry. The increasing demand in pharmaceutical industry is expected to propel the growth of the virus filtration market going forward. Pharmaceutical industry is a sector of the healthcare industry that is involved in the research, development, production, and marketing of drugs and medications used for medical treatment. Virus filtration is used in the production of biopharmaceuticals, vaccines, and other advanced therapies to deliver safe, effective, and high-quality pharmaceutical products to patients. For instance, in May 2024, according to reports published by IQVIA Inc, a US-based pharmaceutical company, in 2023, overall spending growth in the U.S. market for medicines reaching $435 billion at net price level. Total net spending on medicines in 2028 is expected to increase $127 billion compared to 2023 as volume growth drivers, and adoption of innovation will be partly offset by drivers of lower prices, including patent expiries and the effects of legislation. Therefore, increasing demand in pharmaceutical industry is driving the growth of the virus filtration industry.

What Are The Drivers Of The Virus Filtration Market?

The increasing number of chronic diseases is a major driver propelling the growth of the virus filtration market. Chronic diseases refer to conditions that last 1 year or more and need ongoing medical attention or limit activities of daily living. Virus filtration aids in preventing infectious and chronic diseases by removing viruses effectively, supporting the growth of the market. For instance, in June 2023, the Institute for Health Metrics and Evaluation, a US-based public health research institute, reported that over half a billion people globally were living with diabetes. This number is expected to more than double, reaching 1.3 billion people by 2050. Therefore, the rising frequency of cardiovascular illnesses will continue to drive the growth of the virus filtration industry. The increasing demand in pharmaceutical industry is expected to propel the growth of the virus filtration market going forward. Pharmaceutical industry is a sector of the healthcare industry that is involved in the research, development, production, and marketing of drugs and medications used for medical treatment. Virus filtration is used in the production of biopharmaceuticals, vaccines, and other advanced therapies to deliver safe, effective, and high-quality pharmaceutical products to patients. For instance, in May 2024, according to reports published by IQVIA Inc, a US-based pharmaceutical company, in 2023, overall spending growth in the U.S. market for medicines reaching $435 billion at net price level. Total net spending on medicines in 2028 is expected to increase $127 billion compared to 2023 as volume growth drivers, and adoption of innovation will be partly offset by drivers of lower prices, including patent expiries and the effects of legislation. Therefore, increasing demand in pharmaceutical industry is driving the growth of the virus filtration industry.

Global Virus Filtration Market Trends and Insights

Major companies operating in the virus filters market are focusing on developing next-generation high-flux filtration technologies that boost bioprocess productivity, shorten filtration time, and ensure robust viral safety to meet the rising global demand for biotherapeutics. High-flux filtration refers to a filtration process that allows liquids to pass through a membrane at a much faster rate, improving processing speed while still maintaining separation efficiency. For instance, in October 2024, Asahi Kasei Medical, a Japan-based chemical company, has introduced Planova FG1, a next-generation virus removal filter designed to enhance biopharmaceutical manufacturing efficiency. The FG1 delivers roughly seven times higher flux than Planova BioEX, significantly reducing filtration time while maintaining strong virus removal robustness even during process interruptions. Early evaluations showed high protein recovery and consistent performance without the need for prefilters. Compatible with standard CIP and SIP systems, FG1 fits seamlessly into existing production setups. Following its initial release in smaller sizes, the lineup will expand to larger filters, strengthening the Planova™ brand and supporting growing global demand for biotherapeutics.

Regional Outlook

North America was the largest region in the virus filtration market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Virus Filtration Market?

The virus filtration market consists of revenues earned by entities by providing virus filtering services to effectively remove viruses in various processes. The market value includes the value of related goods sold by the service provider or included within the service offering. The virus filtration market also includes sales of filters and systems used to remove viruses. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Virus Filtration Market Report 2026?

The virus filtration market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the virus filtration industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.